TAVERAS ARTHUR (Chief Scientific Officer) sold 16.3% of their position (16.81K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $14.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2023ACC: 0001628280-23-007721
Officer· Chief Scientific Officer
Since Nov 2020
-16.81K
Net shares
Net seller
$14.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.81K
Price / share
$0.84
Trade value
$14.12K
% of position
16.3%
3/10/2023
103.18K→86.37K
Total
Net shares
−16.81K
Net value
-$14.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2023 | S · Sale | −16.81K | $0.84 | $14.12K | 16.3% | 103.18K | 86.37K |
| Total | −16.81K | -$14.12K | ||||||
Derivative Transactions0
No derivative transactions reported